News from REMEDY

The Nor-PAIN study at REMEDY and Diakonhjemmet Hospital has gotten off to an unusually good start. In a short time, 16 patients have already been included, and the researchers describe great interest among the patients. The goal is to include 350 participants in total.

What happens when a researcher passionate about digital patient care gets access to some of the world's most innovative environments in the field? Tuva Moseng says that the study trip broadened her perspectives, opened up new collaborations, and gave her a professional and personal boost that she couldn't have gotten at home.

If you break your hip at an older age, you can have much worse function – and a completely different life. For consultant and postdoctoral researcher Mads Sundet at Diakonhjemmet Hospital, this is the backdrop for the HIFSAT study he leads. This large research project is testing a new surgical method for hip fractures.

Hanne Dagfinrud continues to promote physiotherapy and rehabilitation as a natural part of modern rheumatology treatment. Now she is on her way to passing the baton on.

Now she is about to pass the baton on. The cardiologist paved the way for a new field of expertise when she established the Preventive Rheumatic Heart Disease Clinic at Diakonhjemmet Hospital – the world's first of its kind.

Do you have an idea for a multicenter clinical study? If you work in a company that is part of the National Clinical Network, outside of OUS or Diakonhjemmet Hospital, you can apply. If your idea is good enough, you can get seed funding to develop it! The application deadline is January 20, 2026.

Several rheumatic diseases are linked to hearing loss. Now researchers are trying to figure out who is most at risk – and why.